{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:39:46Z","timestamp":1793047186177,"version":"4.5.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,3]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Activated phosphoinositide 3-kinase \u03b4 syndrome (APDS), a recently described primary immunodeficiency,is caused by autosomal dominant mutation in the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta(PIK3CD) gene encoding the p110\u03b4 catalytic subunit of PI3K\u03b4 (APDS1) or the PIK3R1 gene that encodes the p85\u03b1 regulatory subunit of PI3K\u03b4 (APDS2). Gain-of-function mutation of PIK3CD in APDS1 leads to p110\u03b4 hyperactivity, with the result of the hyperphosphorylation of downstream mediators of Akt and mammalian target of rapamycin that cause a series of clinical symptoms. Few cases with APDS were reported in Asia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We report a 6-year-old patient with a recurrent respiratory infection, cryptosporidium enteritis, lymphoproliferation, high serum immunoglobulin-M level, anemia, and inverted CD4+\/CD8+ ratio. The whole exome sequencing confirmed a heterozygous missense mutation c.3061G&gt;A\uff08p.E1021K\uff09in patient and her mother. Her mutant gene is inherited from her mother, but her mother has not any clinical symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Activated phosphoinositide 3-kinase \u03b4 syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was received immunoglobulin (Ig) replacement therapy, antibiotics, and rapamycin treatment. Through effectively controlling infection and optimal timing of transplantation by adjusting the conditioning regimen, haploidentical Hematopoietic Stem Cell Transplantation(haplo-HSCT) from her brother was successfully performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient is in good condiion with a good quality of life after 20 months of follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We reported a rare APDS1 case with PIK3CD<jats:sup>E1021K<\/jats:sup> gene mutation, Successfully treated with haplo-HSCT. This case provided a reference for treating APDS with haplo-HSCT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032816","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T15:10:08Z","timestamp":1675782608000},"page":"e32816","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Successful haploidentical hematopoietic stem cell transplantation for activated phosphoinositide 3-kinase \u03b4 syndrome: Case report and literature review"],"prefix":"10.1097","volume":"102","author":[{"given":"Xiaolan","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Hematology, The 940th Hospital of Joint Logistics Support Force of Chinese People\u2019s Liberation Army, Lanzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xi","sequence":"additional","affiliation":[{"name":"Department of Hematology, The 940th Hospital of Joint Logistics Support Force of Chinese People\u2019s Liberation Army, Lanzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaofeng","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Hematology, The 940th Hospital of Joint Logistics Support Force of Chinese People\u2019s Liberation Army, Lanzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3111-6933","authenticated-orcid":false,"given":"Yaozhu","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The 940th Hospital of Joint Logistics Support Force of Chinese People\u2019s Liberation Army, Lanzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage.","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in Tcell senescence and human immunodeficiency.","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1172\/JCI81746","article-title":"Erratum: a human immunodeficiency caused by mutations in the PIK3R1 gene.","volume":"125","author":"Deau","year":"2015","journal-title":"J Clin Invest"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1084\/jem.20141759","article-title":"Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K.","volume":"211","author":"Lucas","year":"2014","journal-title":"J Exp Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1172\/JCI75746","article-title":"A human immunodeficiency caused by mutations in the PIK3R1 gene.","volume":"124","author":"Deau","year":"2014","journal-title":"J Clin Invest"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee.","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fimmu.2018.00369","article-title":"Activated PI3 kinase delta syndrome: from genetics to therapy.","volume":"9","author":"Michalovich","year":"2018","journal-title":"Front Immunol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12016-019-08738-9","article-title":"Clinical, Immunological, and Genetic Features in Patients with Activated PI3K\u03b4 Syndrome (APDS): a Systematic Review.","volume":"59","author":"Jamee","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1073\/pnas.1617244114","article-title":"Conformational disruption of PI3Kdelta regulation by immunodeficiency mutations in PIK3CD and PIK3R1.","volume":"114","author":"Dornan","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study.","volume":"139","author":"Coulter","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3389\/fimmu.2018.02043","article-title":"The Treatment of Activated PI3K\u03b4 Syndrome.","volume":"9","author":"Coulter","year":"2018","journal-title":"Front Immunol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/cei.12706","article-title":"Activating PI3K\u03b4 mutations in a cohort of 669 patients with primary immunodeficiency.","volume":"183","author":"Elgizouli","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fimmu.2018.00543","article-title":"Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase \u03b4 syndrome: the European Society for immunodeficiencies-activated phosphoinositide 3-kinase \u03b4 syndrome registry.","volume":"9","author":"Maccari","year":"2018","journal-title":"Front Immunol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \u201cactivated PI3K\u03b4 syndrome\u201d-targeted therapy with the PI3K\u03b4 inhibitor leniolisib.","volume":"130","author":"Rao","year":"2017","journal-title":"Blood"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jaci.2016.09.040","article-title":"Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome.","volume":"139","author":"Nademi","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2021.04.036","article-title":"International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome.","volume":"149","author":"Dimitrova","year":"2022","journal-title":"J Allergy Clin Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:44:42Z","timestamp":1746326682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032816","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}